Clarus Therapeutics Holdings
Northbrook, US · Founded 2020 · Delaware corporation
Biotech
Founders & leadership
JK
Joseph Kenneth HernandezDirector
EA
Elizabeth A. CermakDirector
MA
Mark A. PrygockiDirector
AA
Alex A. ZissonDirector
JK
John Kenneth AmoryDirector
RE
Robert E. DudleyExecutive Officer, Director
RE
Richard E. PetersonExecutive Officer
FK
Frank Kenneth JaegerExecutive Officer
SA
Steven A. BourneExecutive Officer
KK
Kimberly Kenneth MurphyDirector
Reported raises · per SEC filings
Form D private placements▶$15MraisedDec 2021 · 1 investors · PharmaceuticalsRule 506(b)
Officers, directors & promoters on the filing
- Joseph Kenneth HernandezDirector
- Elizabeth A. CermakDirector
- Mark A. PrygockiDirector
- Alex A. ZissonDirector
- John Kenneth AmoryDirector
- Robert E. DudleyExecutive Officer, Director
- Richard E. PetersonExecutive Officer
- Frank Kenneth JaegerExecutive Officer
- Steven A. BourneExecutive Officer
- Kimberly Kenneth MurphyDirector
- Offering amount
- $15M
- Amount sold
- $15M
- Sales commissions
- $900K
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.